Pr ecis: These findings offer an explanation for the longstanding anecdotal anticancer effects of warfarin and support directed clinical evaluation of low dose warfarin and other Axl-targeting agents in cancer patients. Pr ecis: This study presents a unique web resource that enables high-quality analyses to investigate the full spectrum of long-noncoding RNAs in cancer, reducing existing barriers for biomedical researchers to access the complex genomic data, generate testable hypotheses, and make translational discoveries.
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